CNB
DGX icon

Camden National Bank’s Quest Diagnostics DGX Stock Holding History

Camden National Bank’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$283K Sell
1,333
-57
-4% -$11.2K 0.04% 152
2026
Q1 		$272K Hold
1,390
– – 0.04% 137
2025
Q4 		$241K Sell
1,390
-42
-3% -$7.65K 0.03% 154
2025
Q3 		$273K Buy
1,432
+209
+17% +$37.1K 0.04% 140
2025
Q2 		$220K Buy
+1,223
New +$212K 0.03% 154

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Camden National Bank's DGX Position: Q2 2026 in Review

Camden National Bank reduced its Quest Diagnostics (DGX) stake by 4.1% in Q2 2026, selling an estimated $11.2K and leaving 1,333 shares worth $283K. The position accounts for 0.04% of the portfolio, ranked #152.

Camden National Bank first reported a position in DGX in Q2 2025 and has held it in 5 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Camden National Bank held 1,333 shares of Quest Diagnostics worth $283K as of Q2 2026.
  • Camden National Bank sold 57 Quest Diagnostics shares in Q2 2026, an estimated $11.2K.
  • Quest Diagnostics made up 0.04% of Camden National Bank's portfolio in Q2 2026, its #152 holding.
  • Camden National Bank first reported a position in Quest Diagnostics in Q2 2025 and has held it in 5 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Camden National Bank's 13F filing for Q2 2026, filed 31 Jul 2026.